WuXi Biologics: Revenue and profit surged on strong demand for high-margin modalities, with guidance raised
WuXi Biologics: Revenue and profit surged on strong demand for high-margin modalities, with guidance raised
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.